Heart failure nursing care from stage A to the LVAD
Heart failure care runs for years: drug titration, weight logs and admissions that a good plan can prevent. This page follows the patient through the four ACC/AHA/HFSA stages and stays with what the nurse checks, gives and teaches at each one.
Weight of each domain in the 125 scored items; filled squares mark where this topic draws from
IAssessment and Diagnosis (this topic draws on it)22 %
IIPlanning and Implementation (this topic draws on it)35 %
IIIEvaluation and Modification18 %
IVPatient and Community Education (this topic draws on it)25 %
A patient in the emergency department with acute dyspnea has an NT-proBNP of 120 pg/mL. The cardiac-vascular nurse recognizes that:
Choose an option; the reasons for all four open together.
Natriuretic peptides are lower in HFpEF than in HFrEF, but a value this low still argues against acute HF.
NT-proBNP is a stand-alone test with its own cutoffs; a BNP is not needed alongside it.
A low value argues against heart failure; no single low result confirms it.
An NT-proBNP below about 300 pg/mL has a high negative predictive value, so other causes of dyspnea are pursued.
Show the key without choosing
Weight of each domain in the 125 scored items; filled squares mark where this topic draws from
IAssessment and Diagnosis (this topic draws on it)22 %
IIPlanning and Implementation (this topic draws on it)35 %
IIIEvaluation and Modification18 %
IVPatient and Community Education (this topic draws on it)25 %
15 heart failure questions with explained answers
Four answer choices per item; pick the best one.
Tally: 0 right, 0 tried, 15 in this set
Item 2 / 15 · Heart failure
A patient with HFrEF taking metoprolol succinate, furosemide and sacubitril/valsartan reports dizziness on standing. BP is 108/66 mm Hg lying and 86/54 mm Hg standing, HR is 64/min, and weight is 4 lb below the recorded dry weight. The cardiac-vascular nurse suspects:
Worsening heart failure brings weight gain and congestion, not a weight below the dry target.
A heart rate of 64/min is not bradycardia, so the beta-blocker does not explain the symptoms.
A vasovagal episode is brief and does not account for weight loss below the dry weight.
An orthostatic drop with weight 4 lb under dry weight points to too much fluid removed; the diuretic is usually reduced first so the rest of GDMT can continue.
Show the key without choosing
Item 3 / 15 · Heart failure
An 84-year-old patient with heart failure has been readmitted twice in 2 months and takes 11 medications from three prescribers. Which intervention will best identify medication problems?
Looking at the actual bottles shows duplicates, stopped drugs, conflicting prescriptions and missed refills that no list reveals.
A relative's memory of 11 drugs from three prescribers is likely to be incomplete.
Most patients answer yes to this question, so it rarely uncovers the real problem.
The discharge list shows what was intended, not what the patient is actually taking at home.
Show the key without choosing
Item 4 / 15 · Heart failure
A patient enrolled in heart failure telemonitoring transmits a weight 2.5 lb (1.1 kg) higher than yesterday and reports new ankle swelling. The cardiac-vascular nurse's initial action is to:
Changing the dose without an order or a written flexible-diuretic plan is outside the nurse's role.
A quick gain with new edema needs prompt assessment; missed diuretic doses or extra salt are common, fixable causes the call can uncover.
Waiting until the next visit ignores early decompensation that telemonitoring exists to catch.
Sending the patient to the ED before any assessment is premature for a stable-sounding change.
Show the key without choosing
Item 5 / 15 · Heart failure
A patient reports waking at night gasping for air and now sleeps propped on three pillows. These symptoms are caused by:
When the patient lies flat, venous return to the heart rises; a weak left ventricle cannot keep up, so pressure climbs in the pulmonary veins and fluid enters the lungs.
Waking up gasping is a breathing problem from congested lungs, not low blood flow to the brain.
Wheeze can occur, but it comes from congestion; treating it as asthma is the trap.
Right-sided failure shows in the neck veins, liver and legs, not as breathlessness on lying flat.
Show the key without choosing
Item 6 / 15 · Heart failure
The cardiac-vascular nurse is evaluating meal choices by a patient with heart failure who is limiting sodium. Which choice is lowest in sodium?
Canned soup is a major hidden sodium source; "low-fat" describes fat, not salt.
Fresh, unprocessed meat cooked without salt contains little sodium, so it is the lowest of these choices.
Frozen dinners are usually high in sodium; "lean" refers to fat and calories only.
Deli meats are cured with salt, and whole-wheat bread adds more; the healthy-sounding label misleads.
Show the key without choosing
Item 7 / 15 · Heart failure
A patient newly diagnosed with hypertrophic cardiomyopathy asks what it means for their children. The cardiac-vascular nurse explains that the recommendation is to:
Waiting for symptoms or a faint misses relatives whose first event could be sudden death.
HCM is most often genetic; denying that leaves the family unscreened.
Screening starts in childhood and repeats over time; age 40 is far too late.
HCM is usually inherited in an autosomal dominant pattern, and sudden death can be the first sign, so first-degree relatives are screened with ECG and echocardiography.
Show the key without choosing
Item 8 / 15 · Heart failure
A patient with heart failure with reduced ejection fraction is comfortable at rest but becomes short of breath walking to the mailbox, less than one block. The cardiac-vascular nurse documents the patient's NYHA functional class as:
Class II patients tolerate everyday walking and become short of breath only with ordinary exertion such as stairs or a brisk pace.
Breathlessness on a short walk is a clear limitation, so class I is wrong.
Comfortable at rest but breathless after less than one block is symptoms with less-than-ordinary activity, which is class III.
This patient is comfortable at rest, so class IV does not fit.
Show the key without choosing
Item 9 / 15 · Heart failure
A patient with advanced heart failure receiving a dobutamine infusion develops atrial fibrillation with a ventricular rate of 150/min. BP is 102/64 mm Hg and the patient is alert. The cardiac-vascular nurse recognizes that dobutamine:
Beta-1 stimulation speeds AV-node conduction and can provoke AF with a fast ventricular response; the change is reported so the dose can be reviewed.
Dobutamine does the opposite; expecting the rate to settle on its own delays action.
More beta stimulation would push the rate higher still.
Abruptly stopping an inotrope in advanced heart failure can drop output; the nurse reports and expects a planned reduction.
Show the key without choosing
Item 10 / 15 · Heart failure
A patient with heart failure has an implanted pulmonary artery pressure sensor. This week's transmissions show a steady rise in pulmonary artery diastolic pressure, but the patient feels well and weight is stable. The cardiac-vascular nurse's most appropriate action is to:
A steady week-long rise is already a trend; another week adds delay, not certainty.
Pulmonary artery pressure climbs days to weeks before weight or symptoms change; reporting the trend lets diuretics be adjusted early.
Extra fluid would add to congestion when pressures are rising.
Waiting for weight gain throws away the early warning the sensor exists to give.
Show the key without choosing
Item 11 / 15 · Heart failure
Which preventive measure should the cardiac-vascular nurse recommend every year for a patient with chronic heart failure?
Echo is repeated when the clinical picture or treatment decisions change, not on a fixed yearly schedule.
Routine yearly chest films are not recommended without new symptoms.
A stress test looks for ischemia when there is a question to answer; it is not an annual preventive step.
Respiratory infection is a common trigger of decompensation, so a yearly flu shot is advised for people with heart failure.
Show the key without choosing
Item 12 / 15 · Heart failure
A patient with long-standing hypertension has exertional dyspnea and edema. The echocardiogram shows an LVEF of 60% with left ventricular hypertrophy, and BNP is 480 pg/mL. The cardiac-vascular nurse recognizes this as:
That label needs a previous EF of 40% or less that has since risen; no earlier low EF is described.
Heart failure symptoms, an LVEF of 50% or more and signs of high filling pressure, such as a raised BNP and a stiff hypertrophied ventricle, define HFpEF.
A normal EF does not exclude heart failure; assuming it does is how HFpEF gets missed.
The mildly reduced range is 41–49%; an EF of 60% is above it.
Show the key without choosing
Item 13 / 15 · Heart failure
A patient with alcohol-related dilated cardiomyopathy has an LVEF of 25%. Which recommendation offers the best chance of improving ventricular function?
The type of drink does not matter; the alcohol itself injures the myocardium.
Thiamine treats deficiency-related heart disease but does not undo ongoing alcohol injury.
Alcohol is directly toxic to heart muscle; stopping completely, with GDMT, gives the best chance that the ejection fraction recovers.
Continued drinking, even in smaller amounts, is linked with further decline in this cardiomyopathy.
Show the key without choosing
Item 14 / 15 · Heart failure
A patient newly diagnosed with heart failure says, "My heart has failed, so there's nothing I can do." The cardiac-vascular nurse's best response is:
Deferring passes up a teaching moment that is well within the nurse's role.
Promising a cure is false reassurance; heart failure is managed, rarely cured.
Explaining that the heart pumps less well, not that it has stopped, and that medicines and self-care help, gives the patient a reason to take part in care.
Agreeing reinforces the hopelessness, and regular activity is encouraged in stable heart failure.
Show the key without choosing
Item 15 / 15 · Heart failure
A patient with acute decompensated heart failure receives IV furosemide 80 mg twice daily. On day 2, net fluid balance is 3 L negative, weight is down 2.5 kg, and serum potassium is 3.1 mEq/L. The cardiac-vascular nurse's priority is to:
Pushing fluids works against decongestion and does not raise potassium.
The patient is still decongesting as planned; stopping the diuretic treats the lab value by undoing the therapy.
Waiting a day leaves a low potassium untreated during ongoing diuresis.
A potassium of 3.1 mEq/L in a heart failure patient raises the risk of ventricular arrhythmias, so it is reported promptly for replacement while diuresis continues.
Show the key without choosing
–/15
Your tally for this page
Kept in this tab alone: closing or refreshing the tab wipes it.
Stage A, at risk: hypertension, diabetes, obesity, coronary disease or exposure to cardiotoxic drugs, with no structural heart disease yet.
Stage B, pre-heart failure: structural disease, abnormal filling pressures or raised natriuretic peptides, but no symptoms so far.
Stage C, symptomatic heart failure: current or past symptoms.
Stage D, advanced heart failure: symptoms that limit daily life and recurrent admissions despite optimized therapy.
The NYHA functional class is a separate scale. It rates symptoms with activity on the day of the assessment, so a patient's class can improve with treatment, while the stage only moves forward.
The same guideline labels heart failure by left ventricular ejection fraction: reduced (HFrEF), mildly reduced (HFmrEF), preserved (HFpEF) and improved (HFimpEF). The label decides which drugs have trial evidence behind them, which is why the echo report belongs in every handoff.
Guideline-directed therapy: four classes at once
For HFrEF the backbone is four drug classes, often called the four pillars:
an angiotensin receptor-neprilysin inhibitor (sacubitril/valsartan), or, if an ARNI cannot be used, an ACE inhibitor or an ARB;
one of the beta-blockers with mortality data: carvedilol, metoprolol succinate or bisoprolol;
a mineralocorticoid receptor antagonist, spironolactone or eplerenone;
an SGLT2 inhibitor, dapagliflozin or empagliflozin.
The 2022 guideline lets the four start together at low doses, or one after another in an order chosen for the patient, with no need to reach one drug's target dose before the next begins. A beta-blocker can be started before discharge once the patient is clinically stable and no longer needs IV inotropes.
For self-identified Black patients who still have NYHA class III–IV symptoms on optimized therapy, the 2022 guideline adds hydralazine with isosorbide dinitrate. Every start and titration step comes with the vital-sign and lab checks the order or unit protocol names.
Two details of the ARNI change daily work. A switch from an ACE inhibitor needs a 36-hour gap before the first sacubitril/valsartan dose, because taking both together makes angioedema more likely (2022 guideline). And because neprilysin breaks down BNP but not NT-proBNP, BNP rises on the drug while NT-proBNP falls, as the Entresto prescribing information (2026) reports, so a higher BNP alone does not mean decline.
Loop diuretics and the daily weight
ANCC's outline does not name heart failure, but daily weights are one of the two examples it gives for self-management strategies (IV.A.4).
Loop diuretics treat congestion; they relieve breathlessness and edema but have no proven survival benefit, so they run alongside the four classes rather than in place of them. The nursing record around a diuretic is mostly arithmetic: intake and output, the morning weight, and the electrolytes and creatinine drawn on the schedule the order sets.
A weight is only useful as a trend, so the measurement is standardized:
same scale, every morning;
after voiding and before breakfast;
similar clothing, recorded straight into the log.
At home the same routine feeds the patient's heart failure action plan, which names the weight change that should prompt a call. The numbers in that plan come from the prescriber and the program, not from a general rule.
Sodium, fluids and activity at home
Sodium advice is less precise than many handouts suggest. The 2022 guideline rates avoiding excessive sodium as reasonable for symptom control without fixing a number. The SODIUM-HF trial (Lancet, 2022) assigned outpatients with heart failure to a diet below 100 mmol of sodium a day and found no fewer deaths, cardiovascular admissions or emergency visits over 12 months.
Activity is part of treatment. The guideline recommends exercise training for patients who are able to take part and rates a cardiac rehabilitation program as useful; the referral is covered on cardiac rehabilitation. Blood pressure control, the main lever in stage A and in HFpEF, is on hypertension.
Living with a left ventricular assist device
A durable LVAD serves stage D patients as a bridge to transplant, a bridge to a later decision, or destination therapy. With a continuous-flow pump the radial pulse is often weak or absent, which on its own does not signal an arrest, and an automated cuff may fail to read, so pressure is taken with a Doppler and a manual cuff, and the number is recorded and read the way the implanting program's protocol says, against that program's target range.
Home care of the driveline exit site, the controller and the power supply follows the implanting program's teaching plan, and so does the anticoagulant and its INR goal (anticoagulation covers the INR itself).
Cardiomyopathies in brief
Hypertrophic cardiomyopathy: the 2024 AHA/ACC multisociety HCM guideline (2024) assesses sudden death risk for an ICD decision. For symptomatic obstructive disease the cardiac myosin inhibitor mavacamten is dosed by echocardiographic assessment and is available only through a restricted REMS program (Camzyos prescribing information, 2026).
Dilated cardiomyopathy follows the HFrEF pathway above; family history belongs in the interview.
Takotsubo (stress) cardiomyopathy presents like an acute coronary syndrome, with chest pain, ECG changes and a troponin rise.
Which credential covers heart failure nursing on its own?
The CHFN (Certified Heart Failure Nurse), from the American Association of Heart Failure Nurses (AAHFN). That association writes its own exam, rules and renewal, independently of ANCC; the CV-BC treats heart failure as one part of cardiac-vascular nursing.
Are SGLT2 inhibitors only for heart failure patients who have diabetes?
No. The 2022 guideline gives them a class 1 recommendation in symptomatic HFrEF whether or not the patient has diabetes, and a weaker class 2a recommendation in HFmrEF and HFpEF.